Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

NCT02960763 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

742

Enrollment

OTHER

Sponsor class

Conditions

Treatment Resistant Depression
Major Depressive Disorder
Treatment-Refractory Depression
Late Life Depression
Geriatric Depression

Interventions

DRUG: Aripiprazole Augmentation
DRUG: Bupropion Augmentation
DRUG: Switch to bupropion
DRUG: Lithium Augmentation
DRUG: Switch to nortriptyline

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]